BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 25412681)

  • 21. Optimal timing of video-assisted thoracoscopic surgery for patent ductus arteriosus in preterm infants born at ≤ 28 weeks of gestation.
    Kemmochi M; Senzaki H; Miyaji K; Hashimoto M; Yamaguchi A; Ooka M; Yokozeki Y; Ishii M
    Pediatr Int; 2019 Aug; 61(8):792-796. PubMed ID: 31199535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants.
    Mirza H; Garcia J; McKinley G; Hubbard L; Sensing W; Schneider J; Oh W; Wadhawan R
    J Perinatol; 2019 Dec; 39(12):1648-1655. PubMed ID: 31554913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.
    Slaughter JL; Reagan PB; Newman TB; Klebanoff MA
    JAMA Pediatr; 2017 Mar; 171(3):e164354. PubMed ID: 28046188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurodevelopmental outcome after COX inhibitor treatment for patent ductus arteriosus.
    Rheinlaender C; Helfenstein D; Pees C; Walch E; Czernik C; Obladen M; Koehne P
    Early Hum Dev; 2010 Feb; 86(2):87-92. PubMed ID: 20153127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is it possible to predict the success of pharmacological closure of persistent ductus arteriosus in prematurely born neonates?].
    Fendler W; Bernas S; Jarosik K; Piotrowski A
    Anestezjol Intens Ter; 2008; 40(3):156-61. PubMed ID: 19469116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Therapeutic Response to Cyclooxygenase Inhibitors in Preterm Infants with Patent Ductus Arteriosus.
    Hu Y; Jin H; Jiang Y; Du J
    Pediatr Cardiol; 2018 Apr; 39(4):647-652. PubMed ID: 29468349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants.
    Rozé JC; Cambonie G; Marchand-Martin L; Gournay V; Durrmeyer X; Durox M; Storme L; Porcher R; Ancel PY;
    JAMA; 2015 Jun 23-30; 313(24):2441-8. PubMed ID: 26103028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias.
    Mirea L; Sankaran K; Seshia M; Ohlsson A; Allen AC; Aziz K; Lee SK; Shah PS;
    J Pediatr; 2012 Oct; 161(4):689-94.e1. PubMed ID: 22703954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial.
    Gupta S; Juszczak E; Hardy P; Subhedar N; Wyllie J; Kelsall W; Sinha S; Johnson S; Roberts T; Hutchison E; Pepperell J; Linsell L; Bell JL; Stanbury K; Laube M; Edwards C; Field D;
    BMC Pediatr; 2021 Feb; 21(1):100. PubMed ID: 33637074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
    Gentle SJ; Travers CP; Clark M; Carlo WA; Ambalavanan N
    Am J Respir Crit Care Med; 2023 Apr; 207(7):921-928. PubMed ID: 36378949
    [No Abstract]   [Full Text] [Related]  

  • 31. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial.
    Sosenko IR; Fajardo MF; Claure N; Bancalari E
    J Pediatr; 2012 Jun; 160(6):929-35.e1. PubMed ID: 22284563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen.
    Gupta S; Subhedar NV; Bell JL; Field D; Bowler U; Hutchison E; Johnson S; Kelsall W; Pepperell J; Roberts T; Sinha S; Stanbury K; Wyllie J; Hardy P; Juszczak E;
    N Engl J Med; 2024 Jan; 390(4):314-325. PubMed ID: 38265644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants.
    Weisz DE; Mirea L; Rosenberg E; Jang M; Ly L; Church PT; Kelly E; Kim SJ; Jain A; McNamara PJ; Shah PS
    JAMA Pediatr; 2017 May; 171(5):443-449. PubMed ID: 28264088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants?
    Vida VL; Lago P; Salvatori S; Boccuzzo G; Padalino MA; Milanesi O; Speggiorin S; Stellin G
    Ann Thorac Surg; 2009 May; 87(5):1509-15; discussion 1515-6. PubMed ID: 19379895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between platelet count and volume and spontaneous and pharmacological closure of ductus arteriosus in preterm infants.
    Dani C; Poggi C; Fontanelli G
    Am J Perinatol; 2013 May; 30(5):359-64. PubMed ID: 22918676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurodevelopmental Outcome at 2 Years of Age according to Patent Ductus Arteriosus Management in Very Preterm Infants.
    Bourgoin L; Cipierre C; Hauet Q; Basset H; Gournay V; Rozé JC; Flamant C; Gascoin G
    Neonatology; 2016; 109(2):139-46. PubMed ID: 26726863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants.
    Sung SI; Chang YS; Chun JY; Yoon SA; Yoo HS; Ahn SY; Park WS
    J Pediatr; 2016 Oct; 177():66-71.e1. PubMed ID: 27453374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung function in very preterm infants with patent ductus arteriosus under conservative management: an observational study.
    Chen HL; Yang RC; Lee WT; Lee PL; Hsu JH; Wu JR; Dai ZK
    BMC Pediatr; 2015 Oct; 15():167. PubMed ID: 26496854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
    PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.